van Niekerk C C, Boerman O C, Ramaekers F C, Poels L G
Department of Cell Biology, University of Nijmegen, The Netherlands.
Am J Pathol. 1991 Feb;138(2):455-63.
To investigate whether early changes in the transformation of normal ovarian epithelial cells into tumor cells can be detected with monoclonal antibodies, a comparative immunohistochemical study was performed on normal human ovarian mesothelial cells, cystomas, cystadenomas, ovarian carcinomas, as well as granulosa cell tumor. Using monoclonal antibodies against different keratin subtypes, it was shown that mesothelial cells, ovarian cysts, cystadenomas, and carcinomas all reacted positively with broad-spectrum anti-keratin monoclonal antibodies (MAbs), as well as with MAbs to keratins 7, 8, 18, and 19. Keratins 4 and 13 were not found in mesothelial cells, but positive groups of cells were identified in several cystomas, adenomas, and carcinomas. While mesothelial cells did not react with the pan-epithelial marker BW495/36, invaginating metaplastic mesothelial cells, inclusion cysts, cystomas, adenomas, and carcinomas showed an increasing reactivity with BW495/36, with an increasing degree of malignancy. The reactivity of MAbs against ovarian carcinoma-associated antigens (OV-TL 3, OC 125, MOv 18, and OV-TL 10) was limited to weak staining reaction in some mesothelial cells but were found to be positive on more than 50% of the ovarian cystadenomas and more than 90% of the ovarian carcinomas. Thecal and granulosa cells of primordial, primary, and secondary follicles all reacted positively with antibodies to the broad-spectrum keratins OV-TL 12/5 and RCK 102, and to keratins 8 and 18, but not with keratins 4, 7, 13, and 19. These keratins decreased or disappeared in granulosa cells of mature follicles (Graafian follicles), whereas granulosa cell tumors did not react with anti-keratin antibodies. The reactivity of BW 495/36 was negative or limited to traces in some granulosa cells. Ovarian carcinoma-associated antigens were not expressed in granulosa cells or granulosa cell tumors. The data indicate that mesothelial cells undergoing metaplastic changes finally resulting in ovarian cystadenomas (and carcinomas) initiate the synthesis of a 200-kd glycoprotein recognized by MAb (BW 495/36), the production of ovarian carcinoma associated antigens, in addition to focal production of keratin 4 and/or 13, as seen in several samples. The granulosa cell tumors decrease or switch off their keratin production and remain negative for the 200-kd glycoprotein and the ovarian carcinoma-associated antigens.
为了研究能否用单克隆抗体检测正常卵巢上皮细胞向肿瘤细胞转化的早期变化,我们对正常人卵巢间皮细胞、囊肿、囊腺瘤、卵巢癌以及颗粒细胞瘤进行了一项比较性免疫组织化学研究。使用针对不同角蛋白亚型的单克隆抗体,结果显示间皮细胞、卵巢囊肿、囊腺瘤和癌均与广谱抗角蛋白单克隆抗体(MAbs)以及针对角蛋白7、8、18和19的MAbs呈阳性反应。在间皮细胞中未发现角蛋白4和13,但在一些囊肿、腺瘤和癌中发现了阳性细胞群。虽然间皮细胞不与泛上皮标志物BW495/36反应,但内陷化生的间皮细胞、包涵囊肿、囊肿、腺瘤和癌与BW495/36的反应性随着恶性程度的增加而增强。针对卵巢癌相关抗原(OV-TL 3、OC 125、MOv 18和OV-TL 10)的MAbs的反应性在一些间皮细胞中仅限于弱染色反应,但在超过50%的卵巢囊腺瘤和超过90%的卵巢癌中呈阳性。原始卵泡、初级卵泡和次级卵泡的卵泡膜细胞和颗粒细胞均与针对广谱角蛋白OV-TL 12/5和RCK 102以及角蛋白8和18的抗体呈阳性反应,但不与角蛋白4、7、13和19反应。这些角蛋白在成熟卵泡(格拉夫卵泡)的颗粒细胞中减少或消失,而颗粒细胞瘤不与抗角蛋白抗体反应。BW 495/36在一些颗粒细胞中的反应性为阴性或仅限于微量。卵巢癌相关抗原在颗粒细胞或颗粒细胞瘤中不表达。数据表明,经历化生变化最终导致卵巢囊腺瘤(和癌)的间皮细胞开始合成一种被MAb(BW 495/36)识别的200-kd糖蛋白,产生卵巢癌相关抗原,此外,如在几个样本中所见,还局部产生角蛋白4和/或13。颗粒细胞瘤减少或停止其角蛋白产生,并且对200-kd糖蛋白和卵巢癌相关抗原保持阴性。